What is Thompson Miller & Simpson?
Thompson Miller & Simpson PLC operates as a premier litigation and appellate firm, distinguished by its specialized focus on the defense of medical providers, hospital systems, pharmaceutical companies, and product manufacturers. With a legacy spanning over two centuries of combined legal expertise, the firm is recognized for its aggressive defense strategies and its ability to navigate complex, multi-jurisdictional legal landscapes. By prioritizing cost-effective litigation management without compromising on trial outcomes, the firm maintains a competitive edge in a demanding market. Their proven track record in jury trials across multiple states serves as a testament to their technical proficiency and strategic depth in handling high-exposure liability cases.
How much funding has Thompson Miller & Simpson raised?
Thompson Miller & Simpson has raised a total of $719K across 2 funding rounds:
Debt
$350K
Debt
$369K
Debt (2020): $350K with participation from PPP
Debt (2021): $369K led by PPP
Key Investors in Thompson Miller & Simpson
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Thompson Miller & Simpson?
Looking ahead, the firm is well-positioned to scale its litigation support infrastructure and expand its footprint in the corporate defense market. The recent capital injection provides the necessary liquidity to invest in advanced legal technology, talent acquisition, and the expansion of its appellate practice groups. As the firm navigates an increasingly complex regulatory and litigation environment, this strategic financing will likely facilitate further growth in its client base and service offerings. By maintaining a focus on operational efficiency and high-value legal outcomes, Thompson Miller & Simpson is poised to sustain its upward momentum and reinforce its reputation as a leader in the defense litigation sector.
See full Thompson Miller & Simpson company page
